13-hydroxy-9-11-octadecadienoic-acid and 4-hydroxy-2-nonenal

Liver insufficiency and damage are major causes of death and disease worldwide and may result from exposure to environmental toxicants, specific combinations or dosages of pharmaceuticals, and microbial metabolites. The generation of reactive intermediates, in particular 4-hydroxynonenal (4-HNE), is a common event in liver damage caused by a variety of hepatotoxic drugs and solvents. The peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that are involved in the transcriptional regulation of lipid metabolism as well as other biological functions. Importantly, we have observed that the PPARbeta/delta-/- mouse is more susceptible to chemically induced hepatotoxicity than its wild-type counterpart, and our objective in this study was to elucidate the mechanism(s) by which PPARbeta/delta confers protection to hepatocytes. We hypothesized that PPARbeta/delta plays a protective role by responding to toxic lipids and altering gene expression accordingly. In support, oxidized-VLDL and constituents including 13-S-hydroxyoctadecadienoic acid (13-S-HODE) and 4-HNE are PPARbeta/delta ligands. A structure-activity relationship was established where 4-HNE and 4-hydroperoxynonenal (4-HpNE) enhanced the activity of the PPARbeta/delta subtype while 4-hyroxyhexenal (4-HHE), 4-oxo-2-Nonenal (4-ONE), and trans-4,5-epoxy-2(E)-decenal did not activate this receptor. Increasing PPARbeta/delta activity with a synthetic agonist decreased sensitivity of hepatocytes to 4-HNE and other toxic agents, whereas inhibition of this receptor had the opposite result. Gene expression microarray analysis identified several important PPARbeta/delta-regulated detoxification enzymes involved in 4-HNE metabolism that are regulated at the transcript level. This research established 4-HNE as an endogenous modulator of PPARbeta/delta activity and raises the possibility that agonists of this nuclear receptor may be utilized to prevent or treat liver disease associated with oxidative damage.

Topics: 3T3 Cells; Adipocytes; Aldehydes; Animals; Humans; Linoleic Acids; Lipoproteins, VLDL; Mice; Models, Molecular; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Plasmids; PPAR gamma; PPAR-beta; Protein Conformation; RNA, Messenger; Transcription, Genetic

Recently, we established that 13S-hydroperoxy-linoleic acid is converted to 4S-hydroperoxy-nonenal (4S-HPNE) during autoxidation, implicating hydrogen abstraction from C-8 as an initiating step [Schneider, C., et al. (2001) J. Biol. Chem. 275, 20831-20838]. On the basis of the proposed mechanism, an equivalent initiating reaction could occur from the corresponding 13S-hydroxy acid. Herein, we examined the outcome of autoxidation reactions of the omega6 hydroxy fatty acids, 13S-hydroxyoctadecadienoic acid and 15S-hydroxyeicosatetraenoic acid, as compared with reactions of the corresponding hydroperoxy substrates. Autoxidation of the hydroxy starting materials (37 degrees C, dry film) yielded 4-hydroxy-nonenal (4-HNE) as a prominent polar metabolite (and not the 4-hydroperoxide), whereas the hydroperoxide starting materials gave rise to 4-HPNE. Stereochemical analysis showed that the optical purity of the 4-hydroxy group of 4-HNE precisely matched the optical purity of the 15S- or 13S-hydroxy group of the starting fatty acid substrate (98 and 90% S, respectively). The hydroperoxide 15S-HPETE (98% 15S) gave rise to 4S-HPNE, also with retention of optical purity (98% 4S). The preservation of stereochemical configuration provides evidence that aldehyde formation does not involve participation of the hydro(pero)xy group and indicates a similar mechanism for the formation of 4-HNE and 4-HPNE during autoxidation of omega6 hydro(pero)xy fatty acids. Our results establish, moreover, that omega6 hydroxy fatty acids are potential precursors of reactive cytotoxic aldehydes in biological systems.

Topics: Aldehydes; Arachidonic Acid; Eicosanoic Acids; Linoleic Acids; Oxidation-Reduction; Stereoisomerism